NCT01046110 Comparison of NN1250 With Sitagliptin in Subjects With Type 2 Diabetes Never Treated With Insulin Status COMPLETED Phase PHASE3
NCT01045707 Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01045447 Comparison of NN5401 With Insulin Glargine, Both in Combination With Oral Antidiabetic Drugs, in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01044108 A Two Part Trial Investigating an Anti-obesity Drug in Overweight/Obese Male and Female Healthy Volunteers Status TERMINATED Phase PHASE1
NCT01043510 The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin Status COMPLETED Phase PHASE1
NCT01038674 Safety and Tolerability of Anti-IL-20 in Subjects With Rheumatoid Arthritis Status COMPLETED Phase PHASE1
NCT01037582 A Two Part Trial Investigating the Safety of NN9924 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT01034202 Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx® Status COMPLETED Phase PHASE1
NCT01030926 A Trial Investigating the Concentration in the Blood of NN1250 in Children, Adolescents and Adults With Type 1 Diabetes Status COMPLETED Phase PHASE1
NCT01028404 A Two Part Trial Investigating NN1952 in Healthy Subjects and Subjects With Type 1 and Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01024218 Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle Status COMPLETED Phase PHASE4
NCT01022762 Comparison of Repaglinide and Gliclazide in Chinese Subjects With Type 2 Diabetes Never Received Oral Antidiabetic Drug Treatment Status COMPLETED Phase PHASE4
NCT01018238 An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) Status WITHDRAWN Phase PHASE1
NCT01009905 An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone) Status COMPLETED Phase N/A
NCT01009580 Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01006291 Comparison of NN1250 With Insulin Glargine in Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01006057 A Trial Investigating the NN1250 Concentration-time Curve in Subjects With Various Degrees of Renal Impairment and in Subjects With Normal Renal Function Status COMPLETED Phase PHASE1
NCT01002768 Comparison of Hypoglycaemic Response Between NN1250 and Insulin Glargine in Type 1 Diabetics Status COMPLETED Phase PHASE1
NCT00998335 Effect of a Basal/Pre-Meal Insulin Strategy (Detemir/Aspart) on Insulin Secretion and Action in Type 2 Diabetes Status COMPLETED Phase PHASE4